e-therapeutics plc (ETX.L)
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet. The company was incorporated in 2001 and is based in London, the United Kingdom.
Company Info
Highlights
£56.39M
-£0.02
£8.54 - £16.13
£10.00
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in e-therapeutics plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
ETX.L
N/A
N/A
N/A
N/A
N/A
N/A
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of ETX.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 119.96% | -24.28% | -19.85% | -10.23% | 9.22% | ||||||||
| 2023 | -2.42% | -0.31% | -10.59% | -19.69% | 45.55% | 24.89% | -16.83% | -12.63% | -14.78% | -22.74% | -2.74% | -15.49% | -50.06% |
| 2022 | -24.38% | -30.75% | 8.62% | 5.95% | -28.00% | -10.27% | 24.93% | -7.31% | -7.38% | -8.11% | 35.29% | -28.26% | -62.75% |
| 2021 | 6.43% | 28.32% | -11.30% | 53.54% | -17.82% | -15.14% | 7.93% | 14.29% | 26.96% | 14.35% | -1.60% | 10.75% | 153.14% |
| 2020 | 20.97% | 38.67% | 57.21% | 43.73% | 85.11% | -20.69% | -30.14% | 16.18% | 16.07% | -16.15% | 1.83% | 26.13% | 464.52% |
| 2019 | -17.32% | -8.57% | -40.63% | 8.77% | -34.52% | 60.10% | -12.31% | 19.30% | -14.71% | 16.21% | -2.08% | -6.06% | -51.18% |
| 2018 | 4.05% | -9.09% | -11.43% | -6.45% | -0.00% | 5.52% | -7.19% | 16.20% | -10.30% | 1.35% | -11.67% | -4.15% | -31.35% |
| 2017 | 13.11% | -2.90% | 4.48% | -7.14% | -7.69% | 61.67% | 1.03% | -12.24% | -1.16% | -4.71% | -8.64% | 0.00% | 21.31% |
| 2016 | -10.09% | -42.86% | 5.36% | -3.39% | 3.51% | -30.51% | 30.49% | -14.02% | -19.57% | 0.00% | -9.46% | -8.96% | -72.02% |
| 2015 | 14.81% | 25.81% | 0.64% | 3.18% | 0.00% | -3.09% | -1.91% | -15.91% | -15.83% | 7.34% | -4.27% | -2.68% | 0.93% |
| 2014 | -10.89% | 2.22% | 0.00% | 22.83% | 2.65% | -1.72% | 4.39% | -5.88% | 3.57% | -7.76% | 6.54% | -5.26% | 6.93% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ETX.L is 27, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for e-therapeutics plc (ETX.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the e-therapeutics plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the e-therapeutics plc was 97.83%, occurring on Jun 25, 2019. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.83% | Dec 3, 2007 | 2342 | Jun 25, 2019 | — | — | — |
Volatility
Volatility Chart
The current e-therapeutics plc volatility is 29.12%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for e-therapeutics plc.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |